A type 1 diabetic is a person whose immune system has destroyed the insulin-producing cells in their pancreas, leaving them unable to make insulin on their own. Around 9.5 million people worldwide live with this condition. Unlike type 2 diabetes, which involves the body becoming resistant to insulin it still produces, type 1 diabetes is an autoimmune disease that requires lifelong insulin replacement to survive.
How Type 1 Diabetes Develops
In a healthy pancreas, clusters of cells called islets contain beta cells that produce insulin, the hormone that moves sugar from your blood into your cells for energy. In type 1 diabetes, the immune system mistakes these beta cells for a threat and gradually destroys them. The process starts with metabolic stress that triggers the body’s first-line immune defenses. Dying beta cells then activate more specialized immune cells, which ramp up a targeted attack on the islets.
Interestingly, the immune assault is subtler than researchers once assumed. In human type 1 diabetes, fewer than 10% of islets become infiltrated by immune cells, and the infiltration involves only about 15 immune cells per islet, roughly double what you’d see in a healthy person. That relatively small-scale attack is still enough to wipe out insulin production over time. Most people don’t notice symptoms until about 80 to 90% of their beta cells are already gone.
Genetics and Risk Factors
Type 1 diabetes has a strong genetic component, centered on a set of genes in the immune system called HLA genes. Specific variants of these genes, particularly combinations known as DR3 and DR4, are found in the vast majority of people who develop the condition. Carrying both DR3 and DR4 creates an especially high risk because the two variants together produce a unique immune molecule that appears to drive the autoimmune response more aggressively than either one alone.
But genetics alone don’t seal the deal. Most people with high-risk gene variants never develop type 1 diabetes. Environmental triggers, possibly viral infections, dietary factors in early life, or other stressors, seem to be necessary to set the autoimmune process in motion. The condition is most commonly diagnosed in children and teenagers, though it can appear at any age.
How It Differs From Type 2 Diabetes
The core difference is what goes wrong. In type 1, the body produces no insulin because the cells that make it are destroyed. In type 2, the body still makes insulin but can’t use it effectively, a problem called insulin resistance. Type 2 diabetes is closely linked to weight, physical inactivity, and age, while type 1 is not caused by lifestyle factors.
Doctors can distinguish between the two by testing for specific autoantibodies in the blood. Four well-established markers exist: antibodies against insulin itself, an enzyme called GAD, a protein called IA-2, and a zinc transporter known as ZnT8. If one or more of these antibodies are present, the diabetes is autoimmune in nature. People with type 2 diabetes typically test negative for all of them.
Common Symptoms
Type 1 diabetes often comes on faster than type 2. The classic warning signs include excessive thirst, frequent urination, unexplained weight loss, constant fatigue, and blurred vision. These symptoms reflect what happens when sugar builds up in the blood with no insulin to move it into cells: the body tries to flush out the excess sugar through urine, pulling water with it and leaving you dehydrated and hungry for energy your cells can’t access.
In some cases, the first sign of type 1 diabetes is a dangerous complication called diabetic ketoacidosis, or DKA. Without insulin, the body starts breaking down fat for fuel at an accelerated rate, producing acidic compounds called ketones. Early symptoms of DKA include nausea, vomiting, abdominal pain, weakness, and decreased appetite. Left untreated, it can progress to altered consciousness and become life-threatening. DKA is defined by blood sugar above 250 mg/dL, high ketone levels, and blood that becomes dangerously acidic.
Living With Insulin
Every person with type 1 diabetes depends on external insulin, either through injections or an insulin pump. There is no pill form of insulin that works, because stomach acid breaks it down before it can reach the bloodstream. Managing the condition means matching insulin doses to food intake, physical activity, stress levels, and dozens of other variables that affect blood sugar throughout the day.
Several types of insulin serve different purposes. Rapid-acting insulin starts working in about 15 minutes, peaks at one hour, and lasts two to four hours. It’s typically taken right before meals to handle the incoming sugar from food. Long-acting insulin takes about two hours to kick in, has no sharp peak, and provides a steady baseline of insulin for up to 24 hours. Most people with type 1 use a combination of both: a long-acting dose for background coverage and rapid-acting doses around meals.
Continuous glucose monitors have transformed daily management for many people. These small sensors, worn on the skin, check blood sugar every few minutes and send readings to a phone or receiver. Paired with an insulin pump, some systems can automatically adjust insulin delivery based on glucose trends, reducing the mental burden of constant decision-making.
Low Blood Sugar Emergencies
Taking insulin always carries the risk of blood sugar dropping too low, a condition called hypoglycemia. Mild episodes cause shakiness, sweating, confusion, and irritability, and can usually be resolved by eating fast-acting carbohydrates like juice or glucose tablets. Severe hypoglycemia, where a person becomes unable to treat themselves or loses consciousness, requires emergency treatment with glucagon, a hormone that signals the liver to release stored sugar.
Glucagon now comes in three forms: a nasal spray that delivers powdered glucagon through the nose in one step, a pre-mixed injectable pen similar to an EpiPen, and a traditional kit that requires mixing powder with liquid before injection. The nasal spray is often preferred for caregivers because it’s needle-free and straightforward to use under stress. Anyone who lives with or regularly spends time around a person with type 1 diabetes should know where their glucagon is stored and how to use it.
Long-Term Health Considerations
Over years and decades, elevated blood sugar can damage small and large blood vessels throughout the body. The most common complications affect the eyes, kidneys, nerves, and cardiovascular system. Damage to the small blood vessels in the retina (diabetic retinopathy) is the leading cause of new blindness in working-age adults. Nerve damage, particularly in the feet and legs, can cause numbness, tingling, or pain. Kidney damage can progress silently for years before symptoms appear.
The risk of these complications is directly tied to how well blood sugar is controlled over time. A standard blood test called A1C measures average blood sugar over the previous two to three months, giving both the person and their care team a picture of overall control. Keeping A1C lower significantly reduces the risk of every major complication, which is why regular monitoring and insulin adjustment are so central to life with type 1 diabetes.
On average, a person with type 1 diabetes loses about 34 years of healthy life compared to someone without the condition. Much of that gap comes from limited access to insulin and care in lower-income countries, but even in well-resourced settings, the daily demands of managing the disease take a measurable toll on both physical health and quality of life.